The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Chemours (CC) Misses Q4 EPS by 2c, Beats on Revenue; Offers Guidance
February 19, 2026 4:39 PM ESTChemours (NYSE: CC) reported Q4 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
Key Full Year 2026 Outlook5
Consolidated Net Sales growth in the range of 3 to 5%
Adjusted EBITDA between $800... More



